Donald B. Calne

Donald B. Calne publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Donald B. Calne sits on this spectrum.

Donald B. Calne D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Donald B. Calne sits on this spectrum.

Best Publications

• Multiple receptors for dopamine

  Unknown

  3742
  Citations

• Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

  Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner

  3515
  Citations

• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) Report of the NINDS-SPSP International Workshop*

  I. Litvan;Y. Agid;D. Calne;G. Campbell

  2819
  Citations

• Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease

  Raúl de la Fuente-Fernández;Thomas J. Ruth;Vesna Sossi;Michael Schulzer

  1258
  Citations

• Reaction time in Parkinson's disease

  E. V. Evarts;H. Teräväinen;D. B. Calne

  734
  Citations

• Criteria for diagnosing Parkinson's disease

  Unknown

  704
  Citations

• A susceptibility locus for Parkinson's disease maps to chromosome 2p13

  Thomas Gasser;Bertram Müller-Myhsok;Zbigniew K. Wszolek;Ralph Oehlmann

  638
  Citations

• Treatment of spasticity with botulinum toxin: a double-blind study.

  Barry J. Snow;Joseph K. C. Tsui;Mohit H. Bhatt;Michael Varelas

  579
  Citations

• Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

  Francois J. G. Vingerhoets;Michael Schulzer;Donald B. Calne;Barry J. Snow

  492
  Citations

• Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease

  Thomas B. Freeman;C. Warren Olanow;Robert A. Hauser;G. Michael Nauert

  489
  Citations

• Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels

  B. J. Snow;I. Tooyama;I. Tooyama;E. G. McGeer;T. Yamada

  475
  Citations

• Manganism and idiopathic parkinsonism

  Unknown

  464
  Citations

• Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease.

  D B Calne;J W Langston;W R Martin;A J Stoessl

  429
  Citations

• Parkinson's disease: a case-control study of occupational and environmental risk factors

  Clyde Hertzman;Michele Wiens;David Bowering;Barry Snow

  420
  Citations

• Parkinson's disease in 65 pairs of twins and in a set of quadruplets

  Unknown

  393
  Citations

• In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

  Unknown

  381
  Citations

• ALZHEIMER'S DISEASE, PARKINSON'S DISEASE, AND MOTONEURONE DISEASE: ABIOTROPIC INTERACTION BETWEEN AGEING AND ENVIRONMENT?

  D.B Calne;E Mcgeer;A Eisen;P Spencer

  368
  Citations

• Dopamine release in human ventral striatum and expectation of reward.

  Raúl de la Fuente-Fernández;Anthony G Phillips;Mariangela Zamburlini;Vesna Sossi

  366
  Citations

• Nigrostriatal function in humans studied with positron emission tomography

  W. R. W. Martin;M. R. Palmer;C. S. Patlak;D. B. Calne

  364
  Citations

• DCTN1 mutations in Perry syndrome

  Matthew J. Farrer;Mary M. Hulihan;Jennifer M. Kachergus;Justus C Dächsel

  363
  Citations